""Natural Products and their Utilization Pattern" presents recent advancements in the field of natural products research. Secondary metabolites such as phenolics, alkaloids, saponins, lipids, carbohydrates and terpenes synthesized by the plants are commercially important leading to the opportunities in the field of drug development in various herbal industries. The book includes 22 chapters with 11 research and 11 review articles, highlighting different dimensions of commercially useful plant based medicines, neutraceuticals, cosmaceuticals, flavor compounds, their ethnobotany and utilization pattern. Some chapters cover nutritive, pharmacological and economical importance of various plant species such as Momordica charantia, Chenopodium album, Curcuma caesia, Rubus ellipticus, Ocimum sanctum, Diploknema butyracea, Meizotropis pellita, Artemisia, Malus domestica, Angelica glauca, Nardostachys jatamansi, Picrorhiza kurroa, Rheum austral, Swertia chirata and Himalayan lichens. The phytochemical screening and antioxidant potential of some wild edible plants and the indirect organogenesis of Nyctanthes arbor-tristis L. for pharmaceuticals and cosmacuticals were also exemplified. Potential of endophytic fungi as a producer of biologically active natural product has been presented as a review article. Other chapters consider the usefulness of natural products for livelihood generation and societal development of the local hill communities. Book also includes phytoremedial aspect of Vinga radiate. nano based medicines in cancer therapy and novel drug delivery applications. This book is extremely useful resource for natural product chemists, biochemists, botanists, biotechnologists, microbiologists, environmentalists, pharmacologists, researchers post graduate students, academicians and industry persons"--

This book covers the recent innovations relating to various bioactive natural products (such as alkaloids, glycosides, flavonoids, anthraquinones, steroids, polysaccharides, tannins and polyphenolic compounds, volatile oils, fixed oils, fats and waxes, proteins and peptides, vitamins, marine products, camptothecin, piperines, carvacrol, gedunin, GABA, ginsenosides) and their applications in the pharmaceutical fields related to academic, research and industry.

Synthesis of Medicinal Agents from Plants highlights the importance of synthesizing medicinal agents from plants and outlines methods for performing it effectively. Beginning with an introduction to the significance of medicinal plants, the book goes on to provide a historical overview of drug synthesis before exploring how this can be used to successfully replicate and adapt the active agents from natural sources. Chapters then explore the medicinal properties of a number of important plants, before concluding with a discussion of the future of drugs from medicinal plants. Illustrated with real-world examples, it is a practical resource for researchers in this field. In an age of rapid environmental destruction, hundreds of medicinal plants are at risk of extinction from overexploitation and deforestation, limiting the natural resources available for active agent extraction, thereby threatening the discovery of future cures for diseases. Simultaneously, with the increasing population and advances in medical sciences, the demand for drugs is continuously increasing and cannot be met with just plants. The ability to synthetically replicate the active compounds from these plants is essential in creating an ecologically-aware, sustainable future for drug design - Includes detailed coverage of therapeutic compound synthesis - Uses multiple real-world examples to support content - Lays out a sustainable template for the future of developing active agents from natural products

With over 1000 original drawings and 500 photographs, this work offers complete coverage of cell biology, plant physiology and molecular biology.

This report is structured in five parts: national framework for traditional and complementary medicine (T&CM); product regulation; practices and practitioners; the challenges faced by countries; and finally the country profiles. Apart from the section on practices and practitioners the report is consistent with the format of the report of the first global survey in order to provide a useful comparison. The section on practices and practitioners which covers providers education and health insurance is a new section incorporated to reflect the emerging trends in T&CM and to gather new information regarding these topics at a national level. All new information received has been incorporated into individual country profiles and data graphs. The report captures the three phases of progress made by Member States; that is before and after the first WHO Traditional Medicine Strategy (1999?2005) from the first global survey to the second global survey (2005?2012) and from the second survey to the most recent timeline (2012?2018).

The field of cancer therapeutics faces challenges like limited treatment options, adverse side effects, and drug resistance, leaving a critical gap in addressing this disease. Natural Products as Cancer Therapeutics explores the untapped potential of bioactive compounds derived from nature, providing a fresh perspective on cancer treatment. Authored by esteemed scholars, this book comprehensively examines these compounds and their diverse pharmacological benefits. With cutting-edge research, this book has the potential to revolutionize oncology by expanding treatment options and emphasizing the safety and efficacy of natural compounds. It empowers researchers, practitioners, and scholars to explore new avenues in cancer therapeutics, contributing to improved patient outcomes in the ongoing battle against cancer. Embracing the potential of natural products, this book offers a comprehensive and effective approach to combatting cancer.

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.